Role of n-methyl pyrrolidone in the enhancement of aqueous phase transdermal transport

被引:55
作者
Lee, PJ
Langer, R
Shastri, VP [1 ]
机构
[1] MIT, Dept Chem Engn, Cambridge, MA 02139 USA
[2] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37232 USA
关键词
transdermal drug delivery; n-methyl pyrrolidone; lidocaine; hydrophilic; permeation enhancers; formulation; permeability; skin;
D O I
10.1002/jps.20291
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The role of n-methyl pyrrolidone (NMP) as an enhancer for permeants delivered from an aqueous phase was investigated in the transdermal delivery of the local anesthetics lidocaine free base, lidocaine-hydrochloride (HCl), and prilocaine-HCl. Lidocaine free-base flux increased from H2O/NMP binary systems containing over 50% (v/v) NMP with significant flux enhancement observed above 80% NMP. In this range, drug flux was found to correlate with NMP flux. The addition of oleic acid (1% w/v) further enhanced lidocaine flux sixfold, in these formulations. The H2O/NMP (50% v/v) system enhanced the transport of water-soluble hydrochloride salt derivatives of lidocaine and prilocaine by factors of 4.3 and 2.6, respectively, indicating that NMP was capable of enhancing hydrophilic and hydrophobic drugs from an aqueous phase. These findings were consistent with the model that NMP flux across the stratum corneum improves the transport of formulation solutes. (c) 2005 Wiley-Liss, Inc. and the American Pharmacists Association.
引用
收藏
页码:912 / 917
页数:6
相关论文
共 26 条
[1]   Dermal exposure to aqueous solutions of N-methyl pyrrolidone [J].
Akrill, P ;
Cocker, J ;
Dixon, S .
TOXICOLOGY LETTERS, 2002, 134 (1-3) :265-269
[2]  
Asbill CS, 2000, CRIT REV THER DRUG, V17, P621
[3]   EFFECT OF PENETRATION ENHANCERS ON THE PERMEATION OF MANNITOL, HYDROCORTISONE AND PROGESTERONE THROUGH HUMAN-SKIN [J].
BARRY, BW ;
BENNETT, SL .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1987, 39 (07) :535-546
[4]   ETHANOL WATER MUTUALLY ENHANCED TRANSDERMAL THERAPEUTIC SYSTEM .2. SKIN PERMEATION OF ETHANOL AND NITROGLYCERIN [J].
BERNER, B ;
MAZZENGA, GC ;
OTTE, JH ;
STEFFENS, RJ ;
JUANG, RH ;
EBERT, CD .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1989, 78 (05) :402-407
[5]   Probing the effect of vehicles on topical delivery: Understanding the basic relationship between solvent and solute penetration using silicone membranes [J].
Cross, SE ;
Pugh, WJ ;
Hadgraft, J ;
Roberts, MS .
PHARMACEUTICAL RESEARCH, 2001, 18 (07) :999-1005
[6]   OLEIC-ACID - ITS EFFECTS ON STRATUM-CORNEUM IN RELATION TO (TRANS)DERMAL DRUG DELIVERY [J].
FRANCOEUR, ML ;
GOLDEN, GM ;
POTTS, RO .
PHARMACEUTICAL RESEARCH, 1990, 7 (06) :621-627
[7]  
GALE RM, 1987, Patent No. 4645502
[8]   Transdermal delivery of antiparkinsonian agent, benztropine. I. Effect of vehicles on skin permeation [J].
Gorukanti, SR ;
Li, LL ;
Kim, KH .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 192 (02) :159-172
[9]   Mechanistic study of alkyl azacycloheptanones as skin permeation enhancers by permeation and partition experiments with hairless mouse skin [J].
He, N ;
Li, SK ;
Suhonen, TM ;
Warner, KS ;
Higuchi, WI .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2003, 92 (02) :297-310
[10]   Synergistic effects of chemical enhancers and therapeutic ultrasound on transdermal drug delivery [J].
Johnson, ME ;
Mitragotri, S ;
Patel, A ;
Blankschtein, D ;
Langer, R .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1996, 85 (07) :670-679